All articles by Linda Stewart – Page 102
-
News
New study on immune cells interaction unlocks novel treatment targets for Chikungunya virus
Insights from this study open doors for the development of new drugs targeting immune cells to combat CHIKV and similar viruses.
-
News
Staying current with COVID-19 vaccinations helps combat emerging variants
The study is among the first to test in a biosafety level 3 laboratory whether vaccine-elicited antibodies block infection of a live virus.
-
News
Global measles cases almost double in a year
Measles outbreaks are still occurring and in some cases increasing, among a wide variety of countries, raising concerns of an acceleration similar to just before the COVID pandemic. Dr Patrick O’Connor, of WHO Headquarters, Geneva, Switzerland will give an overview of the global measles situation at this ...
-
News
Scientists discover higher levels of CO2 increase survival of viruses in the air and transmission risk
Research shows how CO2 is a major factor in prolonging the life of SARS-CoV-2 variants present in tiny droplets circulating in the atmosphere.
-
News
Negativity about vaccines surged on Twitter after COVID-19 jabs become available
There was a marked increase in negativity about vaccines on Twitter after COVID-19 vaccines became available, while spikes in the number of negative tweets coincided with announcements from healthcare authorities about vaccination.
-
News
Florida dolphin found with highly pathogenic avian flu
The case of a Florida bottlenose dolphin found with highly pathogenic avian influenza virus, or HPAIV — a discovery made by University of Florida researchers in collaboration with multiple other agencies and one of the first reports of a constantly growing list of mammals affected by this virus — has ...
-
News
Antimicrobial resistance crisis: “Antibiotics are not magic bullets”
A pivotal event hosted at the House of Lords on April 29 focused on combating the global crisis of antimicrobial resistance (AMR).
-
News
Study finds resistance to critically important antibiotics in uncooked meat sold for human and animal consumption
New research has found substantial levels of resistance to critically important antibiotics in meat sold for human and animal consumption.
-
News
ChatGPT failed when challenging ESCMID guideline for treating brain abscesses
A new study has found that while ChatGPT seems able to give recommendations on key questions about diagnosis and treatment of brain abscesses in most cases, some of the AI model’s responses could put patients at risk.
-
News
Undocumented Latinx patients got COVID-19 vaccine at same rate as US citizens
For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study has found. These findings surprised researchers, given that COVID-19 disproportionately affected the Latinx ...
-
News
Cervical cancer vaccine very effective in reducing HPV-related disease, but huge variations between countries in coverage
Although evidence is clear that HPV vaccination is reducing cervical cancer incidence and mortality and HPV-related disease, there are high variations in coverage globally, including among high-income countries.
-
News
Study details a common bacterial defense against viral infection
One of the many secrets to bacteria’s success is their ability to defend themselves from viruses, called phages, that infect bacteria and use their cellular machinery to make copies of themselves. Source: Mogana Das Murtey and Patchamuthu Ramasamy Bacillus cereus, SEM image Technological advances have enabled recent ...
-
News
Nonalcoholic fatty liver disease: changes in gut microbiota and blood lipids
This study aimed to explore differences in the gut microbial community and blood lipids between normal livers and those affected by NAFLD using 16S ribosomal deoxyribonucleic acid sequencing.
-
News
Bioinformatics professor discovers surprising evolutionary pattern in landmark yeast study
A new study challenges accepted frameworks within which yeast evolution is studied and provide access to an incredibly rich yeast analysis dataset that could have major implications for future evolutionary biology and bioinformatics research.
-
News
Experts developing immune-enhancing therapies to target tuberculosis
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body’s own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease.
-
News
New tool helps identify babies at high risk for RSV
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
-
News
Gut microbiome continually evolves as pregnancy progresses
A new study reveals the patterns of microbial dysbiosis associated with different pregnancy complications, providing an theoretical basis for elucidating the baseline characteristics of the microbiome in pregnant women.
-
News
Chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and those identifying as Black or multiracial
A recent study of individuals ages 15 to 60 has found that nearly one in five patients with chlamydia and one in four patients with gonorrhea did not receive CDC recommended treatment for their infection.
-
News
Enterovirus paralysis is a serious threat and surveillance and testing systems are desperately needed
Poliomyelitis (polio) has been eliminated in almost all countries of the world - yet non-polio enteroviruses can also lead to the same devastating symptoms of ‘acute flaccid paralysis’ (AFP).
-
News
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to new findings.